Takeda Pharmaceutical (OTCMKTS:TKPYY) Sets New 52-Week Low at $13.27

Shares of Takeda Pharmaceutical Company Limited (OTCMKTS:TKPYY – Get Rating) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $13.27 and last traded at $13.36, with a volume of 2269333 shares changing hands. The stock had previously closed at $13.12.

The business’s 50 day simple moving average is $14.28 and its 200-day simple moving average is $14.41. The stock has a market capitalization of $20.87 billion, a P/E ratio of 12.11 and a beta of 0.42. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.42 and a quick ratio of 1.12.

About Takeda Pharmaceutical (OTCMKTS:TKPYY)

Takeda Pharmaceutical Co, Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products.

Further Reading

• Get a free copy of the StockNews.com research report on Takeda Pharmaceutical (TKPYY)
• This Still Isn’t A Buyable Bottom For Stocks 
• Should Silver Stocks Be A Part Of Your Portfolio?
• ABM Industries, A Clean Play For Dirty Economic Times 
• Don’t Get Too Bullish On Lennar Even Though It’s A Good Buy 
• Dividend-Paying Midstream Oil Companies That Could Help You The Mitigate Market Volatility

Want More Great Investing Ideas?